Radius health, inc. provides abaloparatide business update

Boston, feb. 12, 2021 (globe newswire) -- radius health, inc. (“radius” or the “company”) (nasdaq: rdus) provided a business update on the abaloparatide global business. progress was made, and continues to be made, across the following areas.

RDUS Ratings Summary

RDUS Quant Ranking